NCT01504984View on ClinicalTrials.gov

Crossover Study to Compare Pharmacokinetic Property of SYO-1126 and Glivec Film Coated Tab in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
Healthy
Interventions
DRUG

SYO-1126

Imatinib 400mg/tablet, PO, 1 tablet once daily for I\&II D1(crossover)

DRUG

Glivec film coated tab 4T(400mg)

Imatinib 100mg/tablet, PO, 4 tablets once daily for period I\&II D1(crossover)

Trial Locations (1)

Unknown

Severance hospital, Seoul

All Listed Sponsors
collaborator

Severance Hospital

OTHER

lead

Samyang Biopharmaceuticals Corporation

INDUSTRY

NCT01504984 - Crossover Study to Compare Pharmacokinetic Property of SYO-1126 and Glivec Film Coated Tab in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter